Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-21-000337

Chief Financial Officer acquired 7,857 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2020-12-31 Option exercise +7,857 $5.60 $43,999 333,013 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2020-12-31 Option exercise · Stock Option (right to buy) −7,857 47,793 D: show line 2 in the form
Loading xslF345X03/tm211481d1_4seq1.xml…